Literature DB >> 8140487

Enzyme immunoassays (EIAs) for the detection of anti-Haemophilus ducreyi serum IgA, IgG, and IgM antibodies.

E L Roggen1, G Hoofd, E Van Dyck, P Piot.   

Abstract

BACKGROUND AND OBJECTIVES: Chancroid is a risk factor for heterosexually acquiring HIV. Controlling its spread may reduce HIV transmission. GOAL OF THE STUDY: To develop EIAs for assessing antibody levels and for seroepidemiologic studies. STUDY
DESIGN: Anti-Haemophilus ducreyi IgA, IgG and IgM EIAs were standardized using a crude cocktail antigen. Evaluation was on sera from Kenya, Rwanda, Thailand and The Gambia. The two-tailed student's t test was used to compare results.
RESULTS: The specificity of IgA was 97% (95% confidence interval (CI): 95-99%), of IgG was 92% (95% CI: 89-95%), and of IgM was 99% (95% CI: 98-100%). The sensitivity of IgA was 88% (95% CI: 83-93%), of IgG was 93% (95% CI:89-97%), and of IgM was 78% (95% CI:71-85%) in patients having an ulceration for more than eight days. Thus, 95% (95% CI:92-98%) of the chancroid patients were seropositive for at least one antibody type. The IgG and IgA EIAs were more sensitive in patients older than 24 years of age. Higher IgG rates were found in HIV infected chancroid patients.
CONCLUSION: The EIAs should be useful for studying the kinetics of antibody levels and the epidemiology of H. ducreyi infection.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Age Factors; Antibodies; Asia; Biology; Chancroid; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Epidemiologic Methods; Error Sources; Examinations And Diagnoses; False Negative Reactions; False Positive Reactions; French Speaking Africa; Gambia; Hematologic Tests; Hiv Infections--transmission; Immunity; Immunologic Factors; Infections; Kenya; Laboratory Examinations And Diagnoses; Laboratory Procedures; Measurement; Methodological Studies; Physiology; Population; Population Characteristics; Reproductive Tract Infections; Research Methodology; Research Report; Rwanda; Sexually Transmitted Diseases; Southeastern Asia; Thailand; Viral Diseases; Western Africa

Mesh:

Substances:

Year:  1994        PMID: 8140487     DOI: 10.1097/00007435-199401000-00008

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

Review 1.  Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group.

Authors:  R Hayes; M Wawer; R Gray; J Whitworth; H Grosskurth; D Mabey
Journal:  Genitourin Med       Date:  1997-12

2.  Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands.

Authors:  S M Bruisten; I Cairo; H Fennema; A Pijl; M Buimer; P G Peerbooms; E Van Dyck ; A Meijer; J M Ossewaarde; G J van Doornum
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Etiology of genital ulcer disease in Dakar, Senegal, and comparison of PCR and serologic assays for detection of Haemophilus ducreyi.

Authors:  P A Totten; J M Kuypers; C Y Chen; M J Alfa; L M Parsons; S M Dutro; S A Morse; N B Kiviat
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  The conserved 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi has homology to PAL.

Authors:  S M Spinola; T J Hiltke; K Fortney; K L Shanks
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 5.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

6.  A humoral immune response confers protection against Haemophilus ducreyi infection.

Authors:  Leah E Cole; Kristen L Toffer; Robert A Fulcher; Lani R San Mateo; Paul E Orndorff; Thomas H Kawula
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

7.  In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyi antigens.

Authors:  L Van Laer; J Vingerhoets; G Vanham; L Kestens; J Bwayo; J Otido; P Piot; E Roggen
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

8.  Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraose.

Authors:  S Borrelli; E L Roggen; D Hendriksen; J Jonasson; H J Ahmed; P Piot; P E Jansson; A A Lindberg
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.